Abstract

Novel original robust gain-scheduled controller design for individualized type 1 diabetes mellitus (T1DM) subject model is presented in this paper. For controller design an LPV model is created from insulin-glucose subsystem based on Bergman’s minimal model with subcutaneous insulin absorption and absorption of digested carbohydrates. Identification was performed on pharmacokinetics and pharmacodynamics characteristics of administered insulin and data collected from continuous glucose monitoring (CGM) system. The controller design approach guarantees the closed-loop stability and cost for all scheduled parameter changes. Simulation results show the benefits of the proposed approach.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.